$3.21+7.72%
2026-10-05 closeLoading chart…
Today's signals · No active technical signal.
Signal details →Prime Medicine last closed at $3.21 (+7.72%) on 2026-10-05. Listed on Nasdaq. Trailing 12 months PER is -3.0×. Its overall grade ranks 641 of 741 stocks in Healthcare.
About this company
Prime Medicine last closed at $3.21 (+7.72%) on 2026-10-05. Listed on Nasdaq.
Details →Reported results
Details →
Position in sector
Healthcare · Overall D · 641/741
Valuation grade C
Related stocks
- Vertex PharmaceuticalsCompetitor
유전자편집·희귀질환 치료제 개발 경쟁사
- Editas MedicineCompetitor
CRISPR 기반 유전자편집 치료제 경쟁사
- Intellia TherapeuticsCompetitor
in vivo 유전자편집 치료제 개발 경쟁사
About Prime Medicine
- What technical signals does Prime Medicine (PRME) have?
- Prime Medicine current technical signals: no active technical signal.
- Is Prime Medicine a cup-and-handle pattern?
- No. Prime Medicine has no valid Cup signal right now.
- What published figures are available for Prime Medicine?
- Market cap: $579.44M. Trailing 12 months PER: -3.0×. Latest quarter PBR: 14.29×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-06 dataset
Turn what you saw on this name into a strategy
Ask Q about Prime Medicine, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.
Quantus Signal · live data · not investment advice · Privacy Policy